Sai Life Sciences gains on opening Unit VI facility for veterinary API production in Karnataka
Sai Life Sciences is currently trading at Rs 909.35, up by 15.15 points or 1.69% from its previous closing of Rs 894.20 on the BSE.
The scrip opened at Rs 890.05 and has touched a high and low of Rs 910.95 and Rs 890.05 respectively. So far 8601 shares were traded on the counter.
The BSE group 'B' stock of face value Rs 1 has touched a 52-week high of Rs 943.00 on 25-Aug-2025 and a 52-week low of Rs 635.30 on 09-Apr-2025.
Last one week high and low of the scrip stood at Rs 910.95 and Rs 872.00 respectively. The current market cap of the company is Rs 19094.83 crore.
The promoters holding in the company stood at 35.15%, while Institutions and Non-Institutions held 36.22% and 28.64% respectively.
Sai Life Sciences has opened Unit VI, a dedicated facility for veterinary API production, in Bidar, Karnataka, India, on September 18, 2025. The new facility is designed to meet the highest standards of safety, sustainability, and regulatory compliance, ensuring the production of high-quality APIs for veterinary applications. With this expansion, the company aims to provide efficient and scalable manufacturing solutions to leading global animal health companies.
The new facility leverages advanced technologies, robust supply chain management, and best-in-class safety practices to ensure reliable and cost-effective manufacturing of animal health APIs. The new facility is located alongside the company’s flagship API manufacturing site in Bidar, Karnataka, India (Unit IV Bidar Facility).
Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization.
